Daniel Y. Wang is a board-certified medical oncologist at the Dan L. Duncan Comprehensive Cancer Center in Houston, Texas. He focuses his time on improving the care and coordination of patients with melanoma and sarcoma. Dr. Wang’s research interests include outcomes and immune-related toxicities from immunotherapy. He graduated from Rice University and earned his medical degree at Baylor College of Medicine. He then completed his internal medicine residency at Baylor College of Medicine and his hematology/oncology fellowship at Vanderbilt University.